Biotech Barometer: European-listed biotech companies are showing positive signals despite uneven performances in H2’2019

Editor’s note: This is a sponsored article, which means it is independently written by our editorial team but financially supported by another organisation, in this case, Euronext. If you would like to learn more about sponsored posts on Tech.eu, read this and contact us if you are interested in partnering with us. Euronext and BiotechBourse […]

Seekyo tech.eu

French biotech Seekyo raises €800,000 to test its tumor-targeting smart chemotherapy

Seekyo, a Poitiers-based biotech startup developing new chemotherapies, has raised €800,000 in seed funding to validate its flagship tumor-targeting drug. The financing consists of €400,000 from angel investors in the BAdGE, Investessor, and Synergence networks; a €150,000 loan from the European Investment Fund (EIF) Investment Initiation; and €250,000 in convertible bonds from the French Tech […]

Aqemia tech.eu

Aqemia raises €1 million pre-seed round to disrupt drug discovery market

Aqemia, a Parisian deep tech startup, has raised €1 million pre-seed round from Elaia to develop its molecule matching technology. The company aims to transform pharmaceutical research and disrupt the $60 billion drug discovery market. Aqemia’s core software, developed from academic research at École normale supérieure (PSL), can predict the effectiveness of a pharmaceutical drug. […]

Healx tech.eu

Healx gets $56 million Series B to find treatments for the world’s rare diseases

Cambridge-based Healx, an AI-powered biotech company researching treatments for rare diseases, has raised a $56 million Series B led by Atomico, joined by Intel Capital, Global Brain and btov Partners. The investment enables the company to launch its global Rare Treatment Accelerator programme, as well as pursue ongoing research. Healx is innovating on the traditional […]

Biotech startup Nuritas raises €16 million in Series A funding

Nuritas, an Irish biotech startup, has raised €16 million in a Series A round led by US firm Cultivian Sandbox Ventures. Nuritas has built a medical platform that uses artificial intelligence to analyse peptides in food, which it claims is 500 times faster than current technology. “Our artificial intelligence platform has already disrupted this antiquated […]